Arecor Proprietary Pipeline

Using our Arestat™ technology platform, we are developing enhanced medicines for the treatment of diabetes and other chronic conditions

Tetris Pharma Portfolio

Our specialty pharmaceutical experts in registering, marketing, sales and the distribution of commercial-stage speciality hospital products across the UK and Europe

Our Partners

We partner with leading pharmaceutical and biotechnology companies through technology partnerships to enhance their proprietary products across a range of indications and stages of development

Latest News and Events

  • 30th January 2023

    ARECOR ANNOUNCES PUBLICATION OF PHASE I DATA FOR AT278 IN DIABETES CARE

  • 12th January 2023

    ARECOR ANNOUNCES TRANSFER OF AT307 TO HIKMA

  • 22nd November 2022

    ARECOR TO COMMENCE SECOND CLINICAL TRIAL WITH AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN CANDIDATE FOR TYPE 2 DIABETES